Review of Patient Compliance in Cardiovascular and Diabetes Medications
Author Information
Author(s): Joyce A. Cramer, Ágnes Benedict, Noémi Muszbek, Abdulkadir Keskinaslan, Zeba M. Khan
Primary Institution: Yale University School of Medicine
Hypothesis
Does patient compliance with cardiovascular or antidiabetic medication correlate with clinical outcomes?
Conclusion
Non-compliance with cardiovascular and antidiabetic medication is a significant problem, with only 59% of patients taking medication for more than 80% of their days 'on therapy' in a year.
Supporting Evidence
- Only 63% of patients continue with their medication for a year.
- Patients only take their medication for 72% of the time.
- In 73% of studies, good compliance had a positive effect on clinical outcomes.
- The average 12-month persistence rate was 63%.
- The overall mean medication possession ratio (MPR) was 72%.
- Only 59% of patients had medication for more than 80% of their days 'on therapy' in the year.
- Good compliance has been shown to reduce the risk of adverse cardiovascular outcomes.
Takeaway
Many people forget to take their heart and diabetes medicines, which can make them sicker. If they remember to take their medicines, they usually feel better.
Methodology
The study reviewed 139 papers published between 2000 and 2005 that investigated patient compliance with cardiovascular or antidiabetic medication.
Potential Biases
The study design and methods for calculating compliance/persistence were not always appropriately described.
Limitations
The study may have missed relevant studies or incorrectly categorized them due to one person selecting and extracting the data.
Participant Demographics
The studies included patients with hypertension, diabetes, dyslipidaemia, coronary heart disease, and cardiovascular disease.
Statistical Information
P-Value
p<0.001
Confidence Interval
0.82–0.94
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website